INTRODUCTION
Histone methylation on specific lysine residues is a crucial point for gene expression in eukaryotic cells that is controlled by the opposite action of histone methyltransferases (KMTs), such as Polycomb group proteins, and demethylases (KDMs), such as LSD1 and the family of Jumonji (Jmj) C domain-containing enzymes (1) . Several KDMs have been implicated in development, differentiation or stem cell renewal, and their mutation or deregulation have been linked to cancer and other diseases (2-7).
JMJD3 (KDM6B) and UTX (KDM6A) specifically demethylates di-and tri-methyllysine 27 on histone H3 (H3K27me2/3) (8) (9) (10) . The presence of H3K27me3 at transcriptional sites usually correlates with gene repression (7, 11, 12) , and Polycomb-mediated H3K27 methylation pre-marks genes for DNA methylation and silencing in cancer (13) . Thus, JMJD3 is expected to enable the activation of genes, which indeed occurs for those involved in animal body patterning and the inflammatory response (8, 10, 14, 15) . Moreover, JMJD3 is induced upon activation of the RAS-RAF signalling pathway and contributes to the transcriptional activation of the p16 INK4A tumour suppressor in diploid fibroblasts (16, 17) , and it is aberrantly overexpressed and seems to be involved in Epstein-Barr virus-associated Hodgkin's lymphoma (18) . In addition, JMJD3 appears to have transcriptional effects unrelated to the level of histone methylation at least in lipopolysaccharide-stimulated mouse macrophages, and the possibility of non-histone substrates and/or other activities of KDMs is emerging (19, 20) .
Many epidemiological and preclinical studies suggest a protective effect of vitamin D against several neoplasias, particularly colon cancer, whose confirmation is pending of adequate clinical trials (21) (22) (23) . The active vitamin D metabolite 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ) is a hormone with wide gene regulatory effects in higher organisms (24, 25) , which is in line with the expression of the vitamin D receptor (VDR) in over 30 different cell 4 types (26) . VDR is a member of the nuclear hormone receptor superfamily of transcription factors modulated by ligand, phosphorylation, and perhaps other modifications (27, 28) . We found the strongest change (2 to 3-fold increase at 48 h treatment) for JMJD3, while JMJD4 showed only a 25% decrease and the remaining genes were unaffected (Supplementary Material, Fig. S1 ). To investigate in depth the observed effect we first performed time-course and dose-curve experiments. A progressive increase in JMJD3 RNA level was detected following hormone treatment (10 -7 M) (Fig. 1A ) that was dose-dependent at 48 h (Fig. 1B) .
The general validity and specificity of this finding was examined using a panel of human (Fig. 2C) . JMJD3 knockdown decreased also the basal expression of CDH1/E-cadherin and CST5/cystatin D (Fig. 2C ). These effects were reproduced at the promoter and protein levels: the activity of the CDH1/E-cadherin gene promoter was lower in shJMJD3 than in shControl cells (Fig. 2D) ; likewise, the basal and induced expression of E-cadherin and cystatin D proteins was lower in shJMJD3 cells (Fig. 2E ). In contrast, however, JMJD3 knockdown did not affect the expression of VDR protein ( 
JMJD3 knockdown enhances the expression of epithelial-to-mesenchymal transition inducers
The finding that JMJD3 knockdown affected CDH1/E-cadherin expression and cell phenotype led us to investigate the possibility that these effects could be due to the regulation of genes such as SNAI1, SNAI2, ZEB1 or ZEB2 encoding transcriptional repressors (SNAIL1, SNAIL2,
ZEB1, ZEB2) of CDH1/E-cadherin that are EMT inducers (37). Interestingly, JMJD3
knockdown increased the expression of SNAI1, ZEB1 and ZEB2 RNA without affecting that of SNAI2 RNA (Fig. 3A) , and increased also SNAIL1 and ZEB1 protein levels ( Interestingly, a significant direct correlation was found between the RNA levels of JMJD3 and VDR (Pearson correlation coefficient r = 0.245, P = 0.016) (Fig. 5A ). In contrast, the expression of JMJD3 and SNAI1 RNA showed a strong inverse trend with borderline significance (ANOVA test, P = 0.057) in 82 informative cases (Fig. 5B) .
DISCUSSION
In this study we demonstrate that the human histone H3 lysine demethylase JMJD3 gene is Moreover, the analysis of global transcriptomic studies available in the Oncomine database (http://www.oncomine.org) has previously evidenced reduced JMJD3 expression in several human cancers relative to normal tissues including several hematopoietic malignancies and lung and liver carcinomas (16, 17) . Our study, however, is the first one to measure JMJD3 expression individually in a series of human cancer patients under well-controlled conditions, and together with the results generated in cultured colon cancer cells, it strengthens the previously suggested nature of JMJD3 as a tumour suppressor (16, 17) .
In conclusion, our study uncovers the epigenetic regulator JMJD3 as a new 
MATERIALS AND METHODS

Cells and cell culture
Human cancer cell lines SW480-ADH and SW480-R (32), SW620, SW1417, HCT116, HT29, KM12C, Caco-2, MCF7, MDA-MB-231, MDA-MB-453, UACC-257, SK-MEL-28 and AGS were cultured in DMEM plus 10% foetal bovine serum (Invitrogen, Paisley, UK), except MDA-MB-453 that was cultured in DMEM:F12 (Invitrogen). SW480-ADH shVDR and shControl cells were described previously (29) . All experiments using 1,25(OH) 2 D 3 were performed in medium supplemented with charcoal-treated serum. Phase-contrast images of cultured cells were captured with a Leica DC300 digital camera mounted on an inverted Leitz Labovert FS Microscope. All images were processed using Adobe Photoshop CS5 software (Adobe Systems, San José, CA).
Antibodies and reagents
We used primary mouse monoclonal antibodies against E-cadherin, -catenin (BD After infection cells were selected with 1 g/l puromycin (Sigma-Aldrich) for one week.
Quantitative RT-PCR
RNA was extracted from ~30 mg of tumour or normal tissue and from cultured cells using RNeasy mini kit (Qiagen, Hilden, Germany). RNA was retrotranscribed using the High Capacity cDNA Archive Kit (Applied Biosystems). Primers used for qRT-PCR are listed in Supplementary Material, Table S1 . We also used the following TaqMan probes: JMJD3 
Western blot
Proteins were separated by SDS-PAGE. After blotting onto a PVDF membrane, proteins were revealed following the ECL technique (GE Healthcare, Chalfont St. Gills, UK). Different exposure times of the films were used to ensure that bands were not saturated. Quantification of the films was done by densitometry using ImageJ software.
Immunofluorescence and confocal microscopy
Cells were fixed in methanol at -20ºC for 1 min (E-cadherin, -Tubulin and -Catenin staining) or in p-formaldehyde (F-Actin staining) for 15 min and permeabilized in 0.2% Triton X-100, and then washed four times in PBS. Cells were incubated with the primary antibodies diluted in PBS for 1 h at 37 º C. After four washes in PBS, cells were incubated with secondary antibodies for 45 min at room temperature and washed three times in PBS. For F-Actin staining cells were incubated with Phalloidin-TRITC for 15 min at 37ºC and washed in PBS.
Finally, coverslips containing the cells were mounted using Prolong Gold antifade reagent (Molecular Probes-Invitrogen). Cell imaging was performed on a Leica TCS SP5 DMI6000 microscope using argon ion (488 nm), HeNe (543 nm) and violet diode (405 nm) lasers.
Images were acquired sequentially by direct register using Leica Confocal Software (LAS AF).
Cell proliferation assay (MTT)
This nm. All experiments were performed using triplicates.
In silico screening of VDREs and chromatin immunoprecipitation assays
The sequence surrounding the transcription start site (TSS) of the human JMJD3 gene was obtained from the ENSEMBL database. This TSS was coincident with the ESC-TSS described by Agger et al. (17) . A region spanning 50 kb upstream and 50 kb downstream of the TSS was analyzed for putative VDREs as previously described (53, 54) . The effect of single nucleotide variations on the classical VDRE sequence (AGTTCAnnnAGTTCA) suggested RGKTCA (R=A/G and K=G/T) as the consensus hexameric core sequence for VDREs. We screened for hexamers pairs in DR3, DR4 and ER6 to ER9 orientation fitting the RGKTCA consensus sequence or having at most two deviations from it. We selected the three theoretically best 
Statistical analysis
Results are expressed as mean ± SEM unless otherwise specified. Statistical significance was assessed by two-tailed unpaired Student's t test using the GraphPad Instat3 program.
Differences were considered significant when P < 0.05. The single asterisk indicates P < 0.05, the double asterisk P < 0.01, and the triple asterisk P < 0.001.
The correlation between the tumour versus normal ratio (T/N) of JMJD3 RNA expression and that of VDR in samples from colon cancer patients was studied using the Pearson correlation coefficient. Since SNAI1 RNA was not detected in any normal tissue, the T/N cannot be calculated and its expression was evaluated as presence or absence in tumour tissue. Therefore, correlation between SNAI1 tumour expression and T/N of JMJD3 expression
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was studied using ANOVA test. Associations between clinicopathological parameters and JMJD3 gene expression were studied using ANOVA test. Statistical analysis of gene expression data from colon cancer patients was performed using SPSS software (SPSS, Chicago, IL). Differences were considered statistically significant when P < 0.05. 
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